These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20150005)

  • 1. Losartan and nifedipine therapy in patients with secondary pulmonary hypertension.
    Yilmaz R
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):50-1. PubMed ID: 20150005
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of severe pulmonary hypertension during surgery for congenital heart disease.
    Shyamkrishnan KG; Waikar HD; Titus T
    Indian Heart J; 1996; 48(2):159-60. PubMed ID: 8682557
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension.
    Bozbaş SS; Bozbaş H; Atar A; Ulubay G; Oner Eyüboğlu F
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):43-9. PubMed ID: 20150004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].
    Dubiel JP; Cibor E; Bieron K; Zmuda A; Kostka-Trabka E
    Kardiol Pol; 1988; 31(10):626-32. PubMed ID: 3253452
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic principles of the current treatment of primary pulmonary hypertension].
    Konopleva LF; Revutskiĭ EL; Previr VN
    Kardiologiia; 1984 Oct; 24(10):121-5. PubMed ID: 6394865
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoxia-induced pulmonary hypertension: nifedipine only temporarily reduces pulmonary artery pressure and vascular tone.
    Agostoni P; Doria E; Fiorentini C; Galli C; Tamborini G; Guazzi M
    Ann Ital Med Int; 1989; 4(3):181-3. PubMed ID: 2702029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nifedipine in the treatment of pulmonary hypertension. I--Primary pulmonary hypertension].
    Barreto SM; de Freitas FM
    Arq Bras Cardiol; 1986 May; 46(5):359-64. PubMed ID: 3551892
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary hypertension in high-altitude chronic hypoxia: response to nifedipine.
    Antezana AM; Antezana G; Aparicio O; Noriega I; Velarde FL; Richalet JP
    Eur Respir J; 1998 Nov; 12(5):1181-5. PubMed ID: 9864018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 10. [Noninvasive evaluation of the effectiveness of the treatment of primary pulmonary hypertension. Case report].
    Paczek A; Rydlewska-Sadowska W
    Kardiol Pol; 1987; 30(12):791-7. PubMed ID: 3452680
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the calcium antagonist nifedipine on central and peripheral hemodynamics in patients with primary pulmonary hypertension].
    Khosseĭn A; Mareev VIu; Ageev FT; Sazonova LN; Lobova NM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):78-81. PubMed ID: 3401345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Remote results of the successful treatment with nifedipine of 2 patients with primary pulmonary hypertension].
    Woroszylska M; Piotrowska J; Ruzyłło W; Lubiszewska B
    Kardiol Pol; 1986; 29(3):242-51. PubMed ID: 3773410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of nifedipine in primary pulmonary hypertension.
    Douglas JS
    J Am Coll Cardiol; 1983 Jul; 2(1):174-9. PubMed ID: 6853910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of primary pulmonary hypertension with high doses of nifedipine controlled by Doppler echocardiography].
    Radomyski A; Pasierski T; Torbicki A; Tomkowski W; Filipecki S
    Pneumonol Alergol Pol; 1991; 59(5-6):218-23. PubMed ID: 1843925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is resveratrol the magic bullet for pulmonary hypertension?
    Chicoine LG; Stewart JA; Lucchesi PA
    Hypertension; 2009 Sep; 54(3):473-4. PubMed ID: 19597034
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nifedipine in the treatment of pulmonary hypertension. II--Hypoxic pulmonary hypertension].
    Barreto BM; de Freitas FM
    Arq Bras Cardiol; 1986 Jun; 46(6):425-9. PubMed ID: 3579636
    [No Abstract]   [Full Text] [Related]  

  • 20. Decrease in pulmonary artery pressure with slow release nifedipine in Saudi patients with primary pulmonary hypertension.
    Ribeiro PA; Sivanandan V; Shaikh A; Chalak W; Zaman L; Duran CM
    Rev Port Cardiol; 1991 May; 10(5):413-8. PubMed ID: 1910877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.